BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35320845)

  • 1. Statin Therapy Among Bariatric Patients: The Impact on Metabolic Outcomes and Diabetes Status.
    Mendonça FM; Silva MM; Borges-Canha M; Neves JS; Costa C; Cabral PM; Guerreiro V; Lourenço R; Meira P; Ferreira MJ; Salazar D; Pedro J; Varela A; Souto S; Lau E; Freitas P; Carvalho D; Group C
    Exp Clin Endocrinol Diabetes; 2022 Aug; 130(8):539-545. PubMed ID: 35320845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of statin therapy on weight loss and diabetes in bariatric patients.
    Taylor BA; Ng J; Stone A; Thompson PD; Papasavas PK; Tishler DS
    Surg Obes Relat Dis; 2017 Apr; 13(4):674-680. PubMed ID: 28159561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year effectiveness of bariatric surgery on disease remission, weight loss, and changes of metabolic parameters in obese patients with type 2 diabetes: A population-based propensity score-matched cohort study.
    Wu T; Wong SKH; Law BTT; Grieve E; Wu O; Tong DKH; Leung DKW; Lam CLK; Wong CKH
    Diabetes Metab Res Rev; 2020 Mar; 36(3):e3236. PubMed ID: 31912598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Bariatric Surgery vs Medical Treatment on Type 2 Diabetes in Patients With Body Mass Index Lower Than 35: Five-Year Outcomes.
    Hsu CC; Almulaifi A; Chen JC; Ser KH; Chen SC; Hsu KC; Lee YC; Lee WJ
    JAMA Surg; 2015 Dec; 150(12):1117-24. PubMed ID: 26374954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in weight loss, fasting blood glucose and glycosylated hemoglobin in a sample of 415 obese patients, included in the database of the European accreditation council for excellence centers for bariatric surgery with laparoscopic one anastomosis gastric bypass.
    Carbajo MA; Jiménez JM; Castro MJ; Ortiz-Solórzano J; Arango A
    Nutr Hosp; 2014 Nov; 30(5):1032-8. PubMed ID: 25365005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Beta Cell Function Is Predictive of Diabetes Remission After Bariatric Surgery.
    Souteiro P; Belo S; Neves JS; Magalhães D; Silva RB; Oliveira SC; Costa MM; Saavedra A; Oliveira J; Cunha F; Lau E; Esteves C; Freitas P; Varela A; Queirós J; Carvalho D
    Obes Surg; 2017 Feb; 27(2):288-294. PubMed ID: 27435450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis.
    Ribaric G; Buchwald JN; McGlennon TW
    Obes Surg; 2014 Mar; 24(3):437-55. PubMed ID: 24374842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.
    Panunzi S; De Gaetano A; Carnicelli A; Mingrone G
    Ann Surg; 2015 Mar; 261(3):459-67. PubMed ID: 25361217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
    Malin SK; Bena J; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
    Diabetes Obes Metab; 2014 Dec; 16(12):1230-8. PubMed ID: 25132119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients.
    Bruno G; Gruden G; Barutta F; Cavallo Perin P; Morino M; Toppino M
    Surg Obes Relat Dis; 2015; 11(5):1014-9. PubMed ID: 25979204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Statin Use on Development of New-Onset Diabetes Mellitus in Asian Population.
    Rha SW; Choi BG; Seo HS; Park SH; Park JY; Chen KY; Park Y; Choi SY; Shim MS; Kim JB; Park T; Park J; Lee JJ; Park EJ; Park SH; Choi JY; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Oh DJ
    Am J Cardiol; 2016 Feb; 117(3):382-7. PubMed ID: 26732422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2012 Nov; 11():140. PubMed ID: 23150952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007-2015: A registry-based cohort study.
    Jans A; Näslund I; Ottosson J; Szabo E; Näslund E; Stenberg E
    PLoS Med; 2019 Nov; 16(11):e1002985. PubMed ID: 31747392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders.
    Pournaras DJ; Aasheim ET; Søvik TT; Andrews R; Mahon D; Welbourn R; Olbers T; le Roux CW
    Br J Surg; 2012 Jan; 99(1):100-3. PubMed ID: 22021090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower and higher-potency statins on glycemic control in type 2 diabetes: A retrospective cohort study.
    Bardini G; Giannini S; Rotella CM; Pala L; Cresci B; Mannucci E
    Diabetes Res Clin Pract; 2016 Oct; 120():104-10. PubMed ID: 27525366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different statin therapy to change low-density lipoprotein cholesterol and high-density lipoprotein cholesterol level in Korean patients with and without diabetes.
    Khang AR; Song YS; Kim KM; Moon JH; Lim S; Park KS; Jang HC; Choi SH
    J Clin Lipidol; 2016; 10(3):528-537.e3. PubMed ID: 27206940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
    Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
    J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of fasting morning glucose relative to hemoglobin A1c in normoglycemic patients treated with niacin and with statins.
    Rajanna V; Campbell KB; Leimberger J; Mohanty BD; Guyton JR
    J Clin Lipidol; 2012; 6(2):168-73. PubMed ID: 22385550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Sleeve Gastrectomy "Cure" Diabetes? Long-term Metabolic Effects of Sleeve Gastrectomy in Patients With Type 2 Diabetes.
    Aminian A; Brethauer SA; Andalib A; Punchai S; Mackey J; Rodriguez J; Rogula T; Kroh M; Schauer PR
    Ann Surg; 2016 Oct; 264(4):674-81. PubMed ID: 27433906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.